SlideShare a Scribd company logo
The role of
compliance in
pharmaceutical
cross-border trade
Introduction
 Key Concepts: Globalisation, Global Trade/Cross-Border
(Pharmaceutical)Trade
 Focus on Africa
 Compliance
 Trade (General)
 Pharmaceutical
 Regulators
 NAFDAC
 Nigeria Customs Service
 Industry (Consumer) Angle
 Best Practice
 Summary
Remi ADESEUN
What is Globalisation?
 From the Business Perspective:
 Globalisation is the worldwide movement
toward Economic, financial, Trade, and
communications integration.
 4 Basic Aspects according to IMF:
 trade and transactions,
 capital and investment movements,
 migration and movement of people
 the dissemination of knowledge.[7]
 Ref:International Monetary Fund . (2000). "Globalization:
Threats or Opportunity." 12th April 2000: IMF Publications.
Globalisation: Context & Focus
 Focus of this Paper:
 Global Economic
Integration or
Economic
Globalization
 process by which an
increasing share of
the economic activity
in the world is taking
place between
people from
different countries
What is Global Trade?
 The worldwide business that
involves:
 making and collecting payments
 for transactions in goods and
services,
 and transporting them to
interested markets.

Remi ADESEUN
Global Trade
What is Cross-Border Trade?
 The buying and selling of goods and
services
 between businesses in
neighboring countries,
 with the seller being in one country and
the buyer in the other country, for
example, a company in the United
States selling to a company in Canada.
Or a company in Nigeria selling to a
company in Ghana.
Cross-Border Trade in Africa
 “One of the biggest obstacles to
industrialization in Africa is
that African countries trade very little
between themselves,
 only 10-12 percent of total trade,
whereas regional trade accounts for
63% in EU, 40% in the US and 30%
in Asean countries.”
 Ref: http://kariobangi.com/2012/02/13/are-african-economies-too-
similar/
Cross-Border Trade Environment
For Pharmaceuticals
 Key Requirements for Understanding
 Extensive knowledge of Trade & Customs
Practices around the world
 Deep understanding of
 import and export laws and regulations,
 The Global Supply Chain
 Trade Processes and Controls
 Extensive knowledge of Pharmaceutical
Laws and Regulations
 Forward-thinking attitude/Global Mindset
 Harmonisation of Regulatory Requirements
Cross-Border Pharmaceutical
Trade in Africa
 Harmonisation of Regulatory
Requirements is a key driver for
increased intra-regional trade
 East Africa has made significant
progress in this regard by making
Product Registration in one Country
acceptable for trade in another country
 Leading to improved Compliance and
enhanced Cross-Border Pharmaceutical
Trade
Key Considerations for Successful
Regional Harmonisation in Africa
 A need to adopt a step-wise approach to harmonisation (e.g Start
with Generics)
 A need to invest in regulatory and industry capacity building,
 Acknowledgment that NMRAs must follow through on their mandate
to promote and protect public health
 Sustainability, transparency and trust building
 Use of existing structures and broader REC strategies to advocate
for AMRH
 National sovereignty must be respected,
 Existing forums should be used to provide regulators with practical
advocacy (African Medicines Regulators Conference (AFDRAC),
International Conference for Drug Regulatory Authorities (ICDRA),
International Conference on Harmonisation Global Cooperation Group (ICH-
GCG)
 Need for the Consortium to keep all stakeholders informed and
involved
 Need to capitalise on strategic niche roles of key players
including:WHO, NEPAD, DFID, etc.
Industry’s Goals
 Improve Efficiency
 Harmonisation of Regulatory
Requirements
 Speedier Port Clearance
 Reduce Cost
 Mitigate Risk Issues concerning
conducting cross-border business
What is Trade Compliance
 Trade compliance is the process by
which goods enter into a Country in
conformance with all laws and
regulations of that Country.
 It should be the goal of the Customs
Service to maximize trade compliance
while facilitating the importation of
legitimate cargo.
Drivers of Increased Compliance
Focus in Cross-Border
Pharmaceutical Trade
 tremendous increase in international
trade and transport,
 the growing awareness of trans-
national organized crime and, more
recently,
 the threat of terrorism.
 increased awareness in Customs
administrations that national and and
international co-operation is essential
Pharmaceutical Regulatory Aspects
of Compliance in Cross-Border
Pharmaceutical Trade
 Pharmacy & Drug Laws
 NAFDAC Act, Cap N1 LFN 2004 (formerly Decree 15 of 1993 as
amended) + 14 Subsidiary Regulations
 Drugs and Related Products (Registration, etc) Act Cap F33 LFN 2004
(Formerly Decree 19 of 1993 (as amended)
 Pharmacists Council of Nigeria (PCN) Act 91 of 1992
 Food and Drugs Act Cap 150 LFN (as amended)
 National Drug Formulary and Essential Drugs List Act Cap 252 LFN
1990
 Counterfeit and Fake Drugs and Unwholesome Processed Foods
(Miscellaneous Provisions) Cap 34 LFN 2004 (formerly Decree 25 of
1999)
 Poisons and Pharmacy Act (PPA) Cap 535 LFN 1990
 Dangerous Drugs Act (DDA) Cap 91 LFN 1990
 NDLEA Act of 1989

Remi ADESEUN
NAFDAC
MANDATE
 NAFDAC was established by Decree No. 15 of 1993 (now
NAFDAC Act CAP N1 LFN, 2004) to Regulate and Control the
Importation, Exportation, manufacture, distribution, advertisement,
sale and use of Foods, Drugs, Cosmetics, Medical Devices,
Chemicals, Detergents and packaged water.
 This mandate places on Ports Inspection Directorate (PID) the
responsibility of carrying out the following functions and exercising
powers as described in sections 5d,5e and 5g of the NAFDAC Act.
NAFDAC Act CAP N1 LFN, 2004
5d) undertake inspection of imported food, drugs, cosmetics, medical devices,
bottled water and chemicals and establish relevant quality assurance
systems, including certification of the production sites and of the
regulated products;
5e) compile standard specifications and guidelines for the production,
importation, exportation, sale and distribution of food, drugs, cosmetics,
medical devices, bottled water and chemicals;
5g) control the exportation and issue quality certification of food, drugs,
cosmetics, medical devices, bottled water and chemicals intended for
export.
NAFDAC
 NAFDAC controls the importation and exportation of
all the products covered by this Act at the Sea Ports,
Airports and Land borders.
 No NAFDAC regulated product shall be imported into
and exported out of Nigeria unless it has been duly
registered and/or issued a permit or certificate in
accordance with the provisions of Act Cap F33 LFN 2004
and the accompanying guidelines.
NAFDAC
 To control and inspect imported food, drugs, cosmetics, medical
devices, and chemicals at ports of entry.
 To control the export of food, drugs, cosmetics, medical devices, and
chemicals and issue quality certification of the above products for
export.
 Duties also include compilation of guidelines & regulation for
importation/exportation of regulated products.
 Collaborate with other relevant Agencies, Organizations and the
Private Sector at the Ports and Land Borders.
 Sampling of relevant products for lab analysis before final release
 Implementation of Government fiscal policy on the prohibition of
imports of regulated products through the ports and land borders.
NAFDAC: Functions
 Imposition of sanctions and administrative penalties for violations
including outright seizures for violative products and apprehension
of culprits.
 Operation of 24-hour surveillance at designated airports.
 Organizing seminars, workshops and meetings to sensitize, update
and create awareness on NAFDAC regulations as it concerns imports
and exports.
 Holding Consultative meetings with sectoral groups and
stakeholders to encourage regulatory compliance.
NAFDAC: Functions
A.) IMPORTS:
The divisions in PID ensure proper documentation and
endorsement of customs documents during importation.
The Ports (sea and Air) and Land border offices conduct
physical inspection of goods, Hold assignments, fast track
activities and final release of goods at the various ports and
land borders.
Import Activities occur as:
 Pre-clearance Activities
 Clearance Activities
 Post Clearance Activities
NAFDAC: Operations
B.) EXPORTS:
NAFDAC mandate covers the certification of finished pharmaceutical
products that are meant for export.
The following Certificates are issued on satisfying the requirements for
export:
 Combined Certificate of manufacture and free sale (for registered
products)
 Certificate of Pharmaceutical Products (COPP).
 Free sale Certificates for products not manufactured in Nigeria but
sold in Nigeria.
 Export Certificate for goods transported through Land Borders for
ECOWAS Market.
NAFDAC: Operations
 Pre-Clearance Processes involves
 Pre-arrival notification.
 Clearance Processes involves
 E-Clearance Assessment
 Payment of NAFDAC Charges
 Documentation and First Endorsement
 Physical Inspection
 Second Endorsement
 Release of Goods to importers’ ware
house
NAFDAC: Operations
The Federal Government in her wisdom made laws which
empowers several Government Agencies including NAFDAC to
regulate activities at the Ports.
In the light of this, the Federal Government in 2005 adopted the
Destination Inspection (DI) Scheme.
The objectives of the Destination Inspection Scheme include:
1. To improve clearance of goods by using latest technology tools for
documentary checks risk assessment and on the job training.
2. Facilitate trade through Risk Management and the use of non-
intrusive inspection (x-ray scanners) of imports thereby minimizing
the need for physical examination.
3. To enhance Government import revenue collection and the
detection of illegal and false declaration of imports.
Ports Inspection Directorate
NAFDAC: Operations
 All consignments imported into Nigeria are subjected
to some form of documentary checking and Risk
Assessment. These functions are performed by Nigeria
Customs Service and Webbfontaine Nigeria Limited.
 NAFDAC is connected with Nigeria Customs Service on the
Nigeria Trade Hub at www.nigeriatradehub.gov.ng and
http://trade.gov.ng for ports operations.
 To facilitate legitimate trade, NCS in collaboration with
regulatory agencies have listed all regulated products into
HS Codes, clearing lanes as follows on the next slide:
NAFDAC: Operations
Customs Clearing Lanes
NAFDAC
Customs
Auto release
Output 1
Fast Track
Facility
Output 2
Documentary
Check
Output 3
Scanning
Output 4
Physical
Inspection
Output 5
NAFDAC finished Pharmaceutical products fall under the deep red lane
which is for physical inspection
X
ROUTES FOR DRUGS CLEARANCE
NAFDAC.
Drugs,
Food,
Cosmetics
Medical
Devices,
Agrochemicals,
Raw Materials
Lagos Ports
Drugs,
Food,
Cosmetics
Medical
Devices,
Agrochemicals,
Raw Materials
Airports
Food,
Cosmetics,
Agrochemicals
Land Borders
Food, Cosmetics
Medical
Devices,
Agrochemicals,
Raw Materials
Other Sea Ports
Note: Drug products are not allowed through any port except for Lagos Ports and Airports
NAFDAC: Procedures for Drugs
Clearance
28 5/29/2014
1. Declaration of
importation on
ASYCUDA at
Customs DTI (Direct
Trader Input) Cafe
2. Costing for NAFDAC
Charges NAFDAC
eClearance Unit
3. First Endorsement
of relevant
documents
4. Physical Inspection of
Products at ports and
importer‘s warehouse
5. Submission of relevant
documents for second
endorsement and release
6. Final
Release
NAFDAC: Documents Required for 1st
Stamp for Finished Pharmaceutical
Products
 Letter of undertaking &
Introduction (Original Copy)
 Certificate of Analysis (Original
Copy)
 NAFDAC Certificate of
Registration or Notification
preferably 2013 – 2014
 Electronic SGD
 CRIA (Original) e.g
 *India – QCS, Silis Labs, ACS
 *China – NHU, Hanlin Shangai,
Quangzhou Test Tech.
 *Egypt - ITG
 Photocopy of Payment Advice
 Form C-30
 Annual License to practice as a
Pharmacist
 Retention of Premises
 NAFDAC receipt of payment
 Permit to Import & Permit to Clear
Controlled Substances
 Packing list
 Bill of lading/Airway bill
 Invoice
 Pre-Shipment Information for
Finished Pharmaceutical Products
 Form M
5/29/2014 29
NAFDAC: Documents Required for 2nd
Stamp for Finished Pharmaceutical Products
& Controlled Substances
 Certificate of Analysis/CRIA
 Invoice
 Electronic SGD
 Bill of Lading/Airway Bill
 Form M
 Packing List
 PAAR (Pre-Arrival Assessment Report)
 Physical Examination Sheet
 NAFDAC Reg. Certificate
 Permit to Import & Permit to Clear (Original where
applicable)
5/29/2014 30
5/29/2014 31
Documents not originating from NAFDAC and
used by Nigeria Customs Service for the
clearance of NAFDAC regulated products
S/NO DESCRIPTION
1 Single Goods Declaration
2 Pre Arrival Assessment Report
3 Form M
4 Bill of Lading/Airway Bill
5 Packing List
6 Invoice
Documents not originating from
NAFDAC and used exclusively by
NAFDAC for the clearance of NAFDAC
regulated products
S/NO DESCRIPTION
1
Certificate of Analysis of the
product
2
Pharmacist License and
Premises Licence
3
Clean Report of Inspection &
Analysis (CRIA)
NAFDAC: Operations
5/29/2014 32
Documents originating from NAFDAC and used for the clearance of
NAFDAC regulated products
S/NO DESCRIPTION
1
NARCOTICS AND CONTROLLED SUBSTANCES
DIRECTORATE (NCS)
Permit to import Narcotics substances
Permit to import Psychotropic and Other controlled
Substances
2
CHEMICAL EVALUATION AND RESEARCH DIRECTORATE
(CER)
Permit to import Controlled Chemicals and Solvents
3
REGISTRATION AND REGULATORY AFFAIRS
DIRECTORATE (R&R)
Certificate of Registration/Notification of Registration
Preferably 2013 - 2014
NAFDAC: Operations
Functions of Nigeria Customs
Service in the Nigerian Economy:
i. Revenue Collection
 Customs & Excise Management Act, Cap 84 Laws of the
Federation [CEMA, Section 4], LFN.1990 – power to
control and manage administration of the Customs &
Excise Laws. Collects and account for revenue.
 [ii] Anti – smuggling operations
Applicable at: Borders, sea and airports – checks
contrabands, hazardous goods, national security
interest.
 Physical interception, examination of goods and
documents.
 33
Functions of Nigeria Customs
Service in the Nigerian Economy:
 Agency Function (Inter-Agency)
 NCS performs inter-agency functions on behalf of other
government agencies, namely;
 Nigeria Police Force – seizure of arms and ammunitions.
 National Agency for Food and Drug Administration and Control
[NAFDAC] – prevents illegal importation of foods, drugs and
chemicals.
 National Drug Law Enforcement Agency [NDLEA] – prevents
importation and exportation of hard drugs.
34
Nigeria Customs Service (NCS):Trade
Facilitation Objectives
 Generation of Trade Statistics
 Trade Facilitation
 Trade facilitation at the core of Customs operations
due to the following
 Developments in the WTO with emphasis on trade
liberalization and facilitation.
 Development of Free Trade Areas across the regions
of the world – removing tariff and non-tariff barriers
to speed up economic development .
 NCS strategic positions at the entry and exit points of
Nigerian borders; lead agency role
35
Nigeria Customs Service (NCS):
Trade Facilitation Objectives
 To improve the trade environment and
reduce transactions cost between
business and government.
 To attract Foreign Direct Investment
(FDI).
 To make Nigeria’s borders competitive
by un-impeded flow of goods, services
and investment funds through the
borders.
36
I. Implementation of global best practices as a core objective
of NCS modernization agenda.
II. Revised Kyoto Convention (RKC) on the simplification
and harmonization of Customs procedures- Pre-
lodgement and Pre-registration.
III. WCO guidelines on immediate release of consignment -
PreArrival processing.
IV. Facilitation of trade through provision of adequate &
accurate information in the Nigeria Trade Hub Portal (NTH).
NCS New PAAR Policy
What is PAAR?
•P- Pre
•A- Arrival
•A- Assessment
•R- Report
•Pre-Arrival Assessment Regime allows importer/Agents to
submit import Documents for assessment and issuance of
PAAR (for Clearance) before the arrival of the cargo
PAAR Application provides timely multi-dimensional risk analysis at every
stage of Customs processes.
Risk Management Approach in
Customs Controls
 Risk: The potential for non-compliance
with Customs (& NAFDAC) laws.
 Risk analysis: Systematic use of
available information to determine how
often defined risks may occur and the
magnitude of their likely consequences.
 Risk areas: Those Customs procedures
and categories of international traffic
which present a risk.
Risk Management Approach in
Customs Controls...2
 Risk assessment: The systematic
determination of risk management priorities
by evaluating and comparing the level of
risk against predetermined standards,
target risk levels or other criteria.
 Risk indicators: Specific criteria which,
when taken together, serve as a practical
tool to select and target movements for
their potential for non-compliance with
Customs law.
Risk Management Approach in
Customs Controls...3
 Risk management: Logical and
systematic method of identifying,
analyzing and managing risks. Risk
management can be associated with
any activity, function or process
within the organization and will
enable the organization to take
advantage of opportunities and
minimize potential losses.
Risk Management Approach in
Customs Controls...4
 Risk profile: A predetermined,
comprehensive and relevant
combination of characteristics or risk
indicators, based on information
which has been gathered, analyzed
and categorized.
Risk Management Approach in
Customs Controls...5
 Risk profiling: The means by which Customs
put risk management into practice. It replaces
random examination of documents and goods
with planned and targeted working methods
that use profiles as a basis.
 Standardized Risk Assessments
(SRAs): These Assessments produce risk
indicator products for use by Customs officials
for the purpose of targeting goods and
conveyances in their daily work.
Consumer Protection
 Service Failure
 Arising from Agencies and Service
Providers
 Remedy
 Waive Penalties for Infractions that are
beyond the control of Companies
 Dispute Resolution Mechanism
 No Agency must be allowed to be
Prosecutor, Judge and Jury
Best Practice:
Customs Trade Compliance
 Focused Assessments (FA)
 a detailed review of the company's internal controls for
Customs transactions coupled with an audit of selected import
transactions.
 Goal: determine the company's current level of compliance,
and whether or not there are sufficient systems in place to
ensure a high level of compliance with Customs laws and
regulations for future transactions.
 Outcome: Compliant or Non-Compliant.
 If Non-Compliant, the company will be required to formulate
a compliance improvement plan (CIP), and tender any
revenue found to be owing.
Getting it Right: Facilitation,
not Encumbrance!
Summary
 Globalisation:
 Has led to greatly increased volume of Global and Cross-Border
Trade
 Increased fortunes for developed nations and increased
opportunities for smart developing nations
 Developing nations need to take advantage of Globalisation for
prosperity while avoiding inequalities of wealth distribution
 All need to be aware of the risks that have come with Globalisation
and mitigate against them
 Cross-Border Trade:
 Essentialy between Neighbours
 Regional Cooperation is enlightened self-interest and should be
encouraged
 Inventory the relevant National laws/regulations and harmonise
across the region
 Keep all stakeholders actively informed and involved
Summary
 Trade Compliance:
 Conventionally driven by Customs
 Customs should regularly compile and communicate Compliance
Issues/Breaches to Industry with a view to aiding improvement
 Goal should be facilitation of Trade not encumbrance
 Policy implementation must be customer-centric and culture must
be to protect consumer rights while pursuing National Interest
 Dispute Resolution Systems and Structure must be established
 Cross-Border Pharmaceutical Trade (CBPT):
 Deference should be given to the difference between Professionally
Regulated Pharmaceutical Trade and Trade in General Goods
 There should be greater inter-agency collaboration especially
between Customs and NAFDAC given the key role the latter plays
in regulating CBPT
 Companies need to establish Compliance Management Desks and
give it appropriate Executive Oversight
Thank You!
Contact Information:
Remi ADESEUN
Chairman
Programs Committee
Pharmaceutical Society of Nigeria
08057713769/07065156473
radeseun@gmail.com
r.adeseun@rodot.org

More Related Content

What's hot

Ska
SkaSka
Narcotic drugs and psychotropic substances act, 1985
Narcotic drugs and psychotropic substances act, 1985Narcotic drugs and psychotropic substances act, 1985
Narcotic drugs and psychotropic substances act, 1985
Ravish Yadav
 
National pharmaceutical pricing authority with drugs price control order (dpc...
National pharmaceutical pricing authority with drugs price control order (dpc...National pharmaceutical pricing authority with drugs price control order (dpc...
National pharmaceutical pricing authority with drugs price control order (dpc...
Tushar Morankar
 
The Narcotic Drugs and Psychotropic Substances Act, 1985 with Rules,1985 (Swa...
The Narcotic Drugs and Psychotropic Substances Act, 1985 with Rules,1985 (Swa...The Narcotic Drugs and Psychotropic Substances Act, 1985 with Rules,1985 (Swa...
The Narcotic Drugs and Psychotropic Substances Act, 1985 with Rules,1985 (Swa...
SwatiKhedekar2
 
Mustafa toxicology presentation
Mustafa toxicology presentationMustafa toxicology presentation
Mustafa toxicology presentation
Mustafa Kamal A. Khan
 
Drug pricing policy india
Drug pricing policy indiaDrug pricing policy india
Drug pricing policy india
Anusha Kothakonda
 
National pharmaceutical pricing authority
National pharmaceutical pricing authority National pharmaceutical pricing authority
National pharmaceutical pricing authority
TiyaPatel2
 
Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013
Ganesh Shevalkar
 
NDPS as per PCI
NDPS as per PCINDPS as per PCI
NDPS as per PCI
Shital Kasale
 
Narcotic and psychotropic substances act
Narcotic and psychotropic substances actNarcotic and psychotropic substances act
Narcotic and psychotropic substances act
AkshayChavan116
 
NARCOTIC AND PSHYSCHOTROPIC SUBSTANCES ACT,1985
NARCOTIC AND PSHYSCHOTROPIC SUBSTANCES ACT,1985NARCOTIC AND PSHYSCHOTROPIC SUBSTANCES ACT,1985
NARCOTIC AND PSHYSCHOTROPIC SUBSTANCES ACT,1985
AYURVEDA
 
Narcotics and psychotropic act - Pharma Jury
Narcotics and psychotropic act - Pharma JuryNarcotics and psychotropic act - Pharma Jury
Narcotics and psychotropic act - Pharma Jury
AdarshPatel73
 
Narcotic drugs and psychotropic substance act 1985
Narcotic drugs and psychotropic substance act 1985Narcotic drugs and psychotropic substance act 1985
Narcotic drugs and psychotropic substance act 1985
DeepikshaSahu1
 
The narcotic drugs and psychotropic substances (NDPS) act, 1985 and rules, 1985
The narcotic drugs and psychotropic substances (NDPS) act, 1985 and rules, 1985The narcotic drugs and psychotropic substances (NDPS) act, 1985 and rules, 1985
The narcotic drugs and psychotropic substances (NDPS) act, 1985 and rules, 1985
Ravish Yadav
 
Act related to narcotic and psychotropic substances and illegal drug trafficing
Act related to narcotic and psychotropic substances and illegal drug trafficingAct related to narcotic and psychotropic substances and illegal drug trafficing
Act related to narcotic and psychotropic substances and illegal drug trafficing
Department of Psychiatry, Institute of Medical Sciences. Banaras Hindu University, Varanasi
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)bdvfgbdhg
 
THE NARCOTICS AND PSYCHOTROPIC SUBSTANCES ACT 1985
THE NARCOTICS AND PSYCHOTROPIC SUBSTANCES ACT 1985THE NARCOTICS AND PSYCHOTROPIC SUBSTANCES ACT 1985
THE NARCOTICS AND PSYCHOTROPIC SUBSTANCES ACT 1985
PuttaChandraLekha
 
Narcotic Drugs & Psychotropic substances (NDPS Act )
Narcotic Drugs & Psychotropic substances (NDPS Act )Narcotic Drugs & Psychotropic substances (NDPS Act )
Narcotic Drugs & Psychotropic substances (NDPS Act )
Prashant Jatkar
 
Narcotic drugs and psychotropic substances act 1985
Narcotic drugs and psychotropic substances act 1985Narcotic drugs and psychotropic substances act 1985
Narcotic drugs and psychotropic substances act 1985
M Swetha
 

What's hot (20)

Ska
SkaSka
Ska
 
Drug law & regulations
Drug law & regulationsDrug law & regulations
Drug law & regulations
 
Narcotic drugs and psychotropic substances act, 1985
Narcotic drugs and psychotropic substances act, 1985Narcotic drugs and psychotropic substances act, 1985
Narcotic drugs and psychotropic substances act, 1985
 
National pharmaceutical pricing authority with drugs price control order (dpc...
National pharmaceutical pricing authority with drugs price control order (dpc...National pharmaceutical pricing authority with drugs price control order (dpc...
National pharmaceutical pricing authority with drugs price control order (dpc...
 
The Narcotic Drugs and Psychotropic Substances Act, 1985 with Rules,1985 (Swa...
The Narcotic Drugs and Psychotropic Substances Act, 1985 with Rules,1985 (Swa...The Narcotic Drugs and Psychotropic Substances Act, 1985 with Rules,1985 (Swa...
The Narcotic Drugs and Psychotropic Substances Act, 1985 with Rules,1985 (Swa...
 
Mustafa toxicology presentation
Mustafa toxicology presentationMustafa toxicology presentation
Mustafa toxicology presentation
 
Drug pricing policy india
Drug pricing policy indiaDrug pricing policy india
Drug pricing policy india
 
National pharmaceutical pricing authority
National pharmaceutical pricing authority National pharmaceutical pricing authority
National pharmaceutical pricing authority
 
Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013
 
NDPS as per PCI
NDPS as per PCINDPS as per PCI
NDPS as per PCI
 
Narcotic and psychotropic substances act
Narcotic and psychotropic substances actNarcotic and psychotropic substances act
Narcotic and psychotropic substances act
 
NARCOTIC AND PSHYSCHOTROPIC SUBSTANCES ACT,1985
NARCOTIC AND PSHYSCHOTROPIC SUBSTANCES ACT,1985NARCOTIC AND PSHYSCHOTROPIC SUBSTANCES ACT,1985
NARCOTIC AND PSHYSCHOTROPIC SUBSTANCES ACT,1985
 
Narcotics and psychotropic act - Pharma Jury
Narcotics and psychotropic act - Pharma JuryNarcotics and psychotropic act - Pharma Jury
Narcotics and psychotropic act - Pharma Jury
 
Narcotic drugs and psychotropic substance act 1985
Narcotic drugs and psychotropic substance act 1985Narcotic drugs and psychotropic substance act 1985
Narcotic drugs and psychotropic substance act 1985
 
The narcotic drugs and psychotropic substances (NDPS) act, 1985 and rules, 1985
The narcotic drugs and psychotropic substances (NDPS) act, 1985 and rules, 1985The narcotic drugs and psychotropic substances (NDPS) act, 1985 and rules, 1985
The narcotic drugs and psychotropic substances (NDPS) act, 1985 and rules, 1985
 
Act related to narcotic and psychotropic substances and illegal drug trafficing
Act related to narcotic and psychotropic substances and illegal drug trafficingAct related to narcotic and psychotropic substances and illegal drug trafficing
Act related to narcotic and psychotropic substances and illegal drug trafficing
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)
 
THE NARCOTICS AND PSYCHOTROPIC SUBSTANCES ACT 1985
THE NARCOTICS AND PSYCHOTROPIC SUBSTANCES ACT 1985THE NARCOTICS AND PSYCHOTROPIC SUBSTANCES ACT 1985
THE NARCOTICS AND PSYCHOTROPIC SUBSTANCES ACT 1985
 
Narcotic Drugs & Psychotropic substances (NDPS Act )
Narcotic Drugs & Psychotropic substances (NDPS Act )Narcotic Drugs & Psychotropic substances (NDPS Act )
Narcotic Drugs & Psychotropic substances (NDPS Act )
 
Narcotic drugs and psychotropic substances act 1985
Narcotic drugs and psychotropic substances act 1985Narcotic drugs and psychotropic substances act 1985
Narcotic drugs and psychotropic substances act 1985
 

Viewers also liked

Pharmaceuticals and the WTO TRIPS Agreement
Pharmaceuticals and the WTO TRIPS AgreementPharmaceuticals and the WTO TRIPS Agreement
Pharmaceuticals and the WTO TRIPS Agreement
jboscariol
 
Crystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug PoliciesCrystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug Policiesmerlyna
 
Tracking informal cross border trade in esa comesa trade research forum augu...
Tracking informal cross border trade in esa  comesa trade research forum augu...Tracking informal cross border trade in esa  comesa trade research forum augu...
Tracking informal cross border trade in esa comesa trade research forum augu...
Julliet Wanjiku
 
Compulsory license of Drugs
Compulsory   license   of DrugsCompulsory   license   of Drugs
Compulsory license of Drugs
Mahdy Ali Ahmad Osman
 
Pharmaceutical patent
Pharmaceutical patent Pharmaceutical patent
Food Safety- Nigeria
Food Safety- NigeriaFood Safety- Nigeria
Food Safety- Nigeria
WorldTAP
 
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRYSTUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
Niraj Bartaula
 
Regulatory Trends Of Pharmaceuticals I Bric Countries
Regulatory Trends Of Pharmaceuticals I Bric CountriesRegulatory Trends Of Pharmaceuticals I Bric Countries
Regulatory Trends Of Pharmaceuticals I Bric Countries
shivampharma88
 
How do information services support cross-border trade and investment flows?
How do information services support cross-border trade and investment flows?How do information services support cross-border trade and investment flows?
How do information services support cross-border trade and investment flows?
Hieu Nguyen
 
Wto and implications for small and developing countries
Wto and implications for small and developing countriesWto and implications for small and developing countries
Wto and implications for small and developing countries
Davepres
 
Ch 38 gatt & wto
Ch 38 gatt & wtoCh 38 gatt & wto
Ch 38 gatt & wtoNikita
 
WORLD TRADE ORGANIZATION
WORLD TRADE ORGANIZATIONWORLD TRADE ORGANIZATION
WORLD TRADE ORGANIZATIONKaustubh Gupta
 

Viewers also liked (18)

Pharmaceuticals and the WTO TRIPS Agreement
Pharmaceuticals and the WTO TRIPS AgreementPharmaceuticals and the WTO TRIPS Agreement
Pharmaceuticals and the WTO TRIPS Agreement
 
Crystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug PoliciesCrystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug Policies
 
Tracking informal cross border trade in esa comesa trade research forum augu...
Tracking informal cross border trade in esa  comesa trade research forum augu...Tracking informal cross border trade in esa  comesa trade research forum augu...
Tracking informal cross border trade in esa comesa trade research forum augu...
 
Compulsory license of Drugs
Compulsory   license   of DrugsCompulsory   license   of Drugs
Compulsory license of Drugs
 
Pharmaceutical patent
Pharmaceutical patent Pharmaceutical patent
Pharmaceutical patent
 
Impact on glob
Impact on globImpact on glob
Impact on glob
 
Het oog
Het oogHet oog
Het oog
 
Food Safety- Nigeria
Food Safety- NigeriaFood Safety- Nigeria
Food Safety- Nigeria
 
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRYSTUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
STUDY OF THE NEPALESE PHARMACEUTICAL INDUSTRY
 
Regulatory Trends Of Pharmaceuticals I Bric Countries
Regulatory Trends Of Pharmaceuticals I Bric CountriesRegulatory Trends Of Pharmaceuticals I Bric Countries
Regulatory Trends Of Pharmaceuticals I Bric Countries
 
How do information services support cross-border trade and investment flows?
How do information services support cross-border trade and investment flows?How do information services support cross-border trade and investment flows?
How do information services support cross-border trade and investment flows?
 
Wto Final
Wto FinalWto Final
Wto Final
 
Wto
WtoWto
Wto
 
WTO and Health
WTO and HealthWTO and Health
WTO and Health
 
Wto and implications for small and developing countries
Wto and implications for small and developing countriesWto and implications for small and developing countries
Wto and implications for small and developing countries
 
Ch 38 gatt & wto
Ch 38 gatt & wtoCh 38 gatt & wto
Ch 38 gatt & wto
 
Ipr trips&trims
Ipr trips&trimsIpr trips&trims
Ipr trips&trims
 
WORLD TRADE ORGANIZATION
WORLD TRADE ORGANIZATIONWORLD TRADE ORGANIZATION
WORLD TRADE ORGANIZATION
 

Similar to Compliance in cross border pharmaceutical trade

Drug Regulations in India Dr Surinder Singh.pdf
Drug Regulations in India Dr Surinder Singh.pdfDrug Regulations in India Dr Surinder Singh.pdf
Drug Regulations in India Dr Surinder Singh.pdf
wasimankhan
 
231-Article Text-519-2-10-20180617 (2).pdf
231-Article Text-519-2-10-20180617 (2).pdf231-Article Text-519-2-10-20180617 (2).pdf
231-Article Text-519-2-10-20180617 (2).pdf
apiAspenbioPharmaLab
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
SandhyaPunetha1
 
law of uaeon medical products
law of uaeon medical productslaw of uaeon medical products
law of uaeon medical products
Muhammed hamed albuissa
 
Sanitary and phytosanitary measures
Sanitary and phytosanitary measuresSanitary and phytosanitary measures
Sanitary and phytosanitary measures
karthi keyan
 
Centralize & decentralize regulatory framework of brazil and south africa
Centralize & decentralize regulatory framework of brazil and south africaCentralize & decentralize regulatory framework of brazil and south africa
Centralize & decentralize regulatory framework of brazil and south africa
Harishankar Sahu
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
sandeep bansal
 
Import and export of drugs in india
Import and export of drugs in indiaImport and export of drugs in india
Import and export of drugs in india
Ammar Tasleem
 
regulatory affairs ip ii final
regulatory affairs  ip ii finalregulatory affairs  ip ii final
regulatory affairs ip ii final
Audumbar Mali
 
Regulatory Affairs Introduction.pdf
Regulatory Affairs Introduction.pdfRegulatory Affairs Introduction.pdf
Regulatory Affairs Introduction.pdf
Dr. Ambekar Abdul Wahid
 
Drug regulatory affairs - 1
Drug regulatory affairs - 1Drug regulatory affairs - 1
Drug regulatory affairs - 1
Tanuja Bisht
 
Strategy for enhanced marketing authorization final docx
Strategy for enhanced marketing authorization final docxStrategy for enhanced marketing authorization final docx
Strategy for enhanced marketing authorization final docxFasika Alemu
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy II
Jafarali Masi
 
focus_feb10_md_latin-america[1][1]
focus_feb10_md_latin-america[1][1]focus_feb10_md_latin-america[1][1]
focus_feb10_md_latin-america[1][1]Ynecel Obando
 
Harmonization and it’s impact Theme2
Harmonization and it’s impact Theme2Harmonization and it’s impact Theme2
Harmonization and it’s impact Theme2Naila Kanwal
 
Narcotic Drugs_ An Overview about Narcotics Control Bureau.pdf
Narcotic Drugs_ An Overview about Narcotics Control Bureau.pdfNarcotic Drugs_ An Overview about Narcotics Control Bureau.pdf
Narcotic Drugs_ An Overview about Narcotics Control Bureau.pdf
Free Law - by De Jure
 
Safit2 Rm 5
Safit2 Rm 5Safit2 Rm 5
Safit2 Rm 5FNian
 
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
JAYACHANDRA AKUTHOTA
 
· Read the overview for Module 4· From the textbook, Internation.docx
· Read the overview for Module 4· From the textbook, Internation.docx· Read the overview for Module 4· From the textbook, Internation.docx
· Read the overview for Module 4· From the textbook, Internation.docx
LynellBull52
 
Foreign Trade Law
Foreign Trade LawForeign Trade Law
Foreign Trade Law
Kanchan40
 

Similar to Compliance in cross border pharmaceutical trade (20)

Drug Regulations in India Dr Surinder Singh.pdf
Drug Regulations in India Dr Surinder Singh.pdfDrug Regulations in India Dr Surinder Singh.pdf
Drug Regulations in India Dr Surinder Singh.pdf
 
231-Article Text-519-2-10-20180617 (2).pdf
231-Article Text-519-2-10-20180617 (2).pdf231-Article Text-519-2-10-20180617 (2).pdf
231-Article Text-519-2-10-20180617 (2).pdf
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
law of uaeon medical products
law of uaeon medical productslaw of uaeon medical products
law of uaeon medical products
 
Sanitary and phytosanitary measures
Sanitary and phytosanitary measuresSanitary and phytosanitary measures
Sanitary and phytosanitary measures
 
Centralize & decentralize regulatory framework of brazil and south africa
Centralize & decentralize regulatory framework of brazil and south africaCentralize & decentralize regulatory framework of brazil and south africa
Centralize & decentralize regulatory framework of brazil and south africa
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
 
Import and export of drugs in india
Import and export of drugs in indiaImport and export of drugs in india
Import and export of drugs in india
 
regulatory affairs ip ii final
regulatory affairs  ip ii finalregulatory affairs  ip ii final
regulatory affairs ip ii final
 
Regulatory Affairs Introduction.pdf
Regulatory Affairs Introduction.pdfRegulatory Affairs Introduction.pdf
Regulatory Affairs Introduction.pdf
 
Drug regulatory affairs - 1
Drug regulatory affairs - 1Drug regulatory affairs - 1
Drug regulatory affairs - 1
 
Strategy for enhanced marketing authorization final docx
Strategy for enhanced marketing authorization final docxStrategy for enhanced marketing authorization final docx
Strategy for enhanced marketing authorization final docx
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy II
 
focus_feb10_md_latin-america[1][1]
focus_feb10_md_latin-america[1][1]focus_feb10_md_latin-america[1][1]
focus_feb10_md_latin-america[1][1]
 
Harmonization and it’s impact Theme2
Harmonization and it’s impact Theme2Harmonization and it’s impact Theme2
Harmonization and it’s impact Theme2
 
Narcotic Drugs_ An Overview about Narcotics Control Bureau.pdf
Narcotic Drugs_ An Overview about Narcotics Control Bureau.pdfNarcotic Drugs_ An Overview about Narcotics Control Bureau.pdf
Narcotic Drugs_ An Overview about Narcotics Control Bureau.pdf
 
Safit2 Rm 5
Safit2 Rm 5Safit2 Rm 5
Safit2 Rm 5
 
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
 
· Read the overview for Module 4· From the textbook, Internation.docx
· Read the overview for Module 4· From the textbook, Internation.docx· Read the overview for Module 4· From the textbook, Internation.docx
· Read the overview for Module 4· From the textbook, Internation.docx
 
Foreign Trade Law
Foreign Trade LawForeign Trade Law
Foreign Trade Law
 

More from Remi ADESEUN

Access to Pharmacists is Access to Health-2014 World Pharmacists day ondo psn
Access to Pharmacists is Access to Health-2014 World Pharmacists day ondo psnAccess to Pharmacists is Access to Health-2014 World Pharmacists day ondo psn
Access to Pharmacists is Access to Health-2014 World Pharmacists day ondo psnRemi ADESEUN
 
Change management
Change managementChange management
Change management
Remi ADESEUN
 
Teambuilding for community development moving from conversations-to-collabor...
Teambuilding for community development  moving from conversations-to-collabor...Teambuilding for community development  moving from conversations-to-collabor...
Teambuilding for community development moving from conversations-to-collabor...
Remi ADESEUN
 
Safe medicines for nigerians young pharmacists care
Safe medicines for nigerians young pharmacists careSafe medicines for nigerians young pharmacists care
Safe medicines for nigerians young pharmacists care
Remi ADESEUN
 
Legislation and regulation for best practices in pharmacy ra psn
Legislation and regulation for best practices in pharmacy ra psnLegislation and regulation for best practices in pharmacy ra psn
Legislation and regulation for best practices in pharmacy ra psnRemi ADESEUN
 
Ethics and Integrity in Service-A Presentation made to the Abia State Executi...
Ethics and Integrity in Service-A Presentation made to the Abia State Executi...Ethics and Integrity in Service-A Presentation made to the Abia State Executi...
Ethics and Integrity in Service-A Presentation made to the Abia State Executi...
Remi ADESEUN
 
Towards a better understanding of islam: Focus on islamic banking
Towards a better understanding of islam: Focus on islamic bankingTowards a better understanding of islam: Focus on islamic banking
Towards a better understanding of islam: Focus on islamic bankingRemi ADESEUN
 
Remi Adeseun Presentation on Nigerian Pharma Industry Code of Promotional Pra...
Remi Adeseun Presentation on Nigerian Pharma Industry Code of Promotional Pra...Remi Adeseun Presentation on Nigerian Pharma Industry Code of Promotional Pra...
Remi Adeseun Presentation on Nigerian Pharma Industry Code of Promotional Pra...
Remi ADESEUN
 

More from Remi ADESEUN (8)

Access to Pharmacists is Access to Health-2014 World Pharmacists day ondo psn
Access to Pharmacists is Access to Health-2014 World Pharmacists day ondo psnAccess to Pharmacists is Access to Health-2014 World Pharmacists day ondo psn
Access to Pharmacists is Access to Health-2014 World Pharmacists day ondo psn
 
Change management
Change managementChange management
Change management
 
Teambuilding for community development moving from conversations-to-collabor...
Teambuilding for community development  moving from conversations-to-collabor...Teambuilding for community development  moving from conversations-to-collabor...
Teambuilding for community development moving from conversations-to-collabor...
 
Safe medicines for nigerians young pharmacists care
Safe medicines for nigerians young pharmacists careSafe medicines for nigerians young pharmacists care
Safe medicines for nigerians young pharmacists care
 
Legislation and regulation for best practices in pharmacy ra psn
Legislation and regulation for best practices in pharmacy ra psnLegislation and regulation for best practices in pharmacy ra psn
Legislation and regulation for best practices in pharmacy ra psn
 
Ethics and Integrity in Service-A Presentation made to the Abia State Executi...
Ethics and Integrity in Service-A Presentation made to the Abia State Executi...Ethics and Integrity in Service-A Presentation made to the Abia State Executi...
Ethics and Integrity in Service-A Presentation made to the Abia State Executi...
 
Towards a better understanding of islam: Focus on islamic banking
Towards a better understanding of islam: Focus on islamic bankingTowards a better understanding of islam: Focus on islamic banking
Towards a better understanding of islam: Focus on islamic banking
 
Remi Adeseun Presentation on Nigerian Pharma Industry Code of Promotional Pra...
Remi Adeseun Presentation on Nigerian Pharma Industry Code of Promotional Pra...Remi Adeseun Presentation on Nigerian Pharma Industry Code of Promotional Pra...
Remi Adeseun Presentation on Nigerian Pharma Industry Code of Promotional Pra...
 

Recently uploaded

Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
Care Coordinations
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
RXOOM Healthcare Pvt. Ltd. ​
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
ranishasharma67
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
preciousstephanie75
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
KRISTELLEGAMBOA2
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 

Recently uploaded (20)

Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 

Compliance in cross border pharmaceutical trade

  • 1. The role of compliance in pharmaceutical cross-border trade
  • 2. Introduction  Key Concepts: Globalisation, Global Trade/Cross-Border (Pharmaceutical)Trade  Focus on Africa  Compliance  Trade (General)  Pharmaceutical  Regulators  NAFDAC  Nigeria Customs Service  Industry (Consumer) Angle  Best Practice  Summary Remi ADESEUN
  • 3. What is Globalisation?  From the Business Perspective:  Globalisation is the worldwide movement toward Economic, financial, Trade, and communications integration.  4 Basic Aspects according to IMF:  trade and transactions,  capital and investment movements,  migration and movement of people  the dissemination of knowledge.[7]  Ref:International Monetary Fund . (2000). "Globalization: Threats or Opportunity." 12th April 2000: IMF Publications.
  • 4. Globalisation: Context & Focus  Focus of this Paper:  Global Economic Integration or Economic Globalization  process by which an increasing share of the economic activity in the world is taking place between people from different countries
  • 5. What is Global Trade?  The worldwide business that involves:  making and collecting payments  for transactions in goods and services,  and transporting them to interested markets.  Remi ADESEUN
  • 7. What is Cross-Border Trade?  The buying and selling of goods and services  between businesses in neighboring countries,  with the seller being in one country and the buyer in the other country, for example, a company in the United States selling to a company in Canada. Or a company in Nigeria selling to a company in Ghana.
  • 8. Cross-Border Trade in Africa  “One of the biggest obstacles to industrialization in Africa is that African countries trade very little between themselves,  only 10-12 percent of total trade, whereas regional trade accounts for 63% in EU, 40% in the US and 30% in Asean countries.”  Ref: http://kariobangi.com/2012/02/13/are-african-economies-too- similar/
  • 9. Cross-Border Trade Environment For Pharmaceuticals  Key Requirements for Understanding  Extensive knowledge of Trade & Customs Practices around the world  Deep understanding of  import and export laws and regulations,  The Global Supply Chain  Trade Processes and Controls  Extensive knowledge of Pharmaceutical Laws and Regulations  Forward-thinking attitude/Global Mindset  Harmonisation of Regulatory Requirements
  • 10. Cross-Border Pharmaceutical Trade in Africa  Harmonisation of Regulatory Requirements is a key driver for increased intra-regional trade  East Africa has made significant progress in this regard by making Product Registration in one Country acceptable for trade in another country  Leading to improved Compliance and enhanced Cross-Border Pharmaceutical Trade
  • 11. Key Considerations for Successful Regional Harmonisation in Africa  A need to adopt a step-wise approach to harmonisation (e.g Start with Generics)  A need to invest in regulatory and industry capacity building,  Acknowledgment that NMRAs must follow through on their mandate to promote and protect public health  Sustainability, transparency and trust building  Use of existing structures and broader REC strategies to advocate for AMRH  National sovereignty must be respected,  Existing forums should be used to provide regulators with practical advocacy (African Medicines Regulators Conference (AFDRAC), International Conference for Drug Regulatory Authorities (ICDRA), International Conference on Harmonisation Global Cooperation Group (ICH- GCG)  Need for the Consortium to keep all stakeholders informed and involved  Need to capitalise on strategic niche roles of key players including:WHO, NEPAD, DFID, etc.
  • 12. Industry’s Goals  Improve Efficiency  Harmonisation of Regulatory Requirements  Speedier Port Clearance  Reduce Cost  Mitigate Risk Issues concerning conducting cross-border business
  • 13. What is Trade Compliance  Trade compliance is the process by which goods enter into a Country in conformance with all laws and regulations of that Country.  It should be the goal of the Customs Service to maximize trade compliance while facilitating the importation of legitimate cargo.
  • 14. Drivers of Increased Compliance Focus in Cross-Border Pharmaceutical Trade  tremendous increase in international trade and transport,  the growing awareness of trans- national organized crime and, more recently,  the threat of terrorism.  increased awareness in Customs administrations that national and and international co-operation is essential
  • 15. Pharmaceutical Regulatory Aspects of Compliance in Cross-Border Pharmaceutical Trade  Pharmacy & Drug Laws  NAFDAC Act, Cap N1 LFN 2004 (formerly Decree 15 of 1993 as amended) + 14 Subsidiary Regulations  Drugs and Related Products (Registration, etc) Act Cap F33 LFN 2004 (Formerly Decree 19 of 1993 (as amended)  Pharmacists Council of Nigeria (PCN) Act 91 of 1992  Food and Drugs Act Cap 150 LFN (as amended)  National Drug Formulary and Essential Drugs List Act Cap 252 LFN 1990  Counterfeit and Fake Drugs and Unwholesome Processed Foods (Miscellaneous Provisions) Cap 34 LFN 2004 (formerly Decree 25 of 1999)  Poisons and Pharmacy Act (PPA) Cap 535 LFN 1990  Dangerous Drugs Act (DDA) Cap 91 LFN 1990  NDLEA Act of 1989  Remi ADESEUN
  • 16. NAFDAC MANDATE  NAFDAC was established by Decree No. 15 of 1993 (now NAFDAC Act CAP N1 LFN, 2004) to Regulate and Control the Importation, Exportation, manufacture, distribution, advertisement, sale and use of Foods, Drugs, Cosmetics, Medical Devices, Chemicals, Detergents and packaged water.  This mandate places on Ports Inspection Directorate (PID) the responsibility of carrying out the following functions and exercising powers as described in sections 5d,5e and 5g of the NAFDAC Act.
  • 17. NAFDAC Act CAP N1 LFN, 2004 5d) undertake inspection of imported food, drugs, cosmetics, medical devices, bottled water and chemicals and establish relevant quality assurance systems, including certification of the production sites and of the regulated products; 5e) compile standard specifications and guidelines for the production, importation, exportation, sale and distribution of food, drugs, cosmetics, medical devices, bottled water and chemicals; 5g) control the exportation and issue quality certification of food, drugs, cosmetics, medical devices, bottled water and chemicals intended for export. NAFDAC
  • 18.  NAFDAC controls the importation and exportation of all the products covered by this Act at the Sea Ports, Airports and Land borders.  No NAFDAC regulated product shall be imported into and exported out of Nigeria unless it has been duly registered and/or issued a permit or certificate in accordance with the provisions of Act Cap F33 LFN 2004 and the accompanying guidelines. NAFDAC
  • 19.  To control and inspect imported food, drugs, cosmetics, medical devices, and chemicals at ports of entry.  To control the export of food, drugs, cosmetics, medical devices, and chemicals and issue quality certification of the above products for export.  Duties also include compilation of guidelines & regulation for importation/exportation of regulated products.  Collaborate with other relevant Agencies, Organizations and the Private Sector at the Ports and Land Borders.  Sampling of relevant products for lab analysis before final release  Implementation of Government fiscal policy on the prohibition of imports of regulated products through the ports and land borders. NAFDAC: Functions
  • 20.  Imposition of sanctions and administrative penalties for violations including outright seizures for violative products and apprehension of culprits.  Operation of 24-hour surveillance at designated airports.  Organizing seminars, workshops and meetings to sensitize, update and create awareness on NAFDAC regulations as it concerns imports and exports.  Holding Consultative meetings with sectoral groups and stakeholders to encourage regulatory compliance. NAFDAC: Functions
  • 21. A.) IMPORTS: The divisions in PID ensure proper documentation and endorsement of customs documents during importation. The Ports (sea and Air) and Land border offices conduct physical inspection of goods, Hold assignments, fast track activities and final release of goods at the various ports and land borders. Import Activities occur as:  Pre-clearance Activities  Clearance Activities  Post Clearance Activities NAFDAC: Operations
  • 22. B.) EXPORTS: NAFDAC mandate covers the certification of finished pharmaceutical products that are meant for export. The following Certificates are issued on satisfying the requirements for export:  Combined Certificate of manufacture and free sale (for registered products)  Certificate of Pharmaceutical Products (COPP).  Free sale Certificates for products not manufactured in Nigeria but sold in Nigeria.  Export Certificate for goods transported through Land Borders for ECOWAS Market. NAFDAC: Operations
  • 23.  Pre-Clearance Processes involves  Pre-arrival notification.  Clearance Processes involves  E-Clearance Assessment  Payment of NAFDAC Charges  Documentation and First Endorsement  Physical Inspection  Second Endorsement  Release of Goods to importers’ ware house NAFDAC: Operations
  • 24. The Federal Government in her wisdom made laws which empowers several Government Agencies including NAFDAC to regulate activities at the Ports. In the light of this, the Federal Government in 2005 adopted the Destination Inspection (DI) Scheme. The objectives of the Destination Inspection Scheme include: 1. To improve clearance of goods by using latest technology tools for documentary checks risk assessment and on the job training. 2. Facilitate trade through Risk Management and the use of non- intrusive inspection (x-ray scanners) of imports thereby minimizing the need for physical examination. 3. To enhance Government import revenue collection and the detection of illegal and false declaration of imports. Ports Inspection Directorate NAFDAC: Operations
  • 25.  All consignments imported into Nigeria are subjected to some form of documentary checking and Risk Assessment. These functions are performed by Nigeria Customs Service and Webbfontaine Nigeria Limited.  NAFDAC is connected with Nigeria Customs Service on the Nigeria Trade Hub at www.nigeriatradehub.gov.ng and http://trade.gov.ng for ports operations.  To facilitate legitimate trade, NCS in collaboration with regulatory agencies have listed all regulated products into HS Codes, clearing lanes as follows on the next slide: NAFDAC: Operations
  • 26. Customs Clearing Lanes NAFDAC Customs Auto release Output 1 Fast Track Facility Output 2 Documentary Check Output 3 Scanning Output 4 Physical Inspection Output 5 NAFDAC finished Pharmaceutical products fall under the deep red lane which is for physical inspection X
  • 27. ROUTES FOR DRUGS CLEARANCE NAFDAC. Drugs, Food, Cosmetics Medical Devices, Agrochemicals, Raw Materials Lagos Ports Drugs, Food, Cosmetics Medical Devices, Agrochemicals, Raw Materials Airports Food, Cosmetics, Agrochemicals Land Borders Food, Cosmetics Medical Devices, Agrochemicals, Raw Materials Other Sea Ports Note: Drug products are not allowed through any port except for Lagos Ports and Airports
  • 28. NAFDAC: Procedures for Drugs Clearance 28 5/29/2014 1. Declaration of importation on ASYCUDA at Customs DTI (Direct Trader Input) Cafe 2. Costing for NAFDAC Charges NAFDAC eClearance Unit 3. First Endorsement of relevant documents 4. Physical Inspection of Products at ports and importer‘s warehouse 5. Submission of relevant documents for second endorsement and release 6. Final Release
  • 29. NAFDAC: Documents Required for 1st Stamp for Finished Pharmaceutical Products  Letter of undertaking & Introduction (Original Copy)  Certificate of Analysis (Original Copy)  NAFDAC Certificate of Registration or Notification preferably 2013 – 2014  Electronic SGD  CRIA (Original) e.g  *India – QCS, Silis Labs, ACS  *China – NHU, Hanlin Shangai, Quangzhou Test Tech.  *Egypt - ITG  Photocopy of Payment Advice  Form C-30  Annual License to practice as a Pharmacist  Retention of Premises  NAFDAC receipt of payment  Permit to Import & Permit to Clear Controlled Substances  Packing list  Bill of lading/Airway bill  Invoice  Pre-Shipment Information for Finished Pharmaceutical Products  Form M 5/29/2014 29
  • 30. NAFDAC: Documents Required for 2nd Stamp for Finished Pharmaceutical Products & Controlled Substances  Certificate of Analysis/CRIA  Invoice  Electronic SGD  Bill of Lading/Airway Bill  Form M  Packing List  PAAR (Pre-Arrival Assessment Report)  Physical Examination Sheet  NAFDAC Reg. Certificate  Permit to Import & Permit to Clear (Original where applicable) 5/29/2014 30
  • 31. 5/29/2014 31 Documents not originating from NAFDAC and used by Nigeria Customs Service for the clearance of NAFDAC regulated products S/NO DESCRIPTION 1 Single Goods Declaration 2 Pre Arrival Assessment Report 3 Form M 4 Bill of Lading/Airway Bill 5 Packing List 6 Invoice Documents not originating from NAFDAC and used exclusively by NAFDAC for the clearance of NAFDAC regulated products S/NO DESCRIPTION 1 Certificate of Analysis of the product 2 Pharmacist License and Premises Licence 3 Clean Report of Inspection & Analysis (CRIA) NAFDAC: Operations
  • 32. 5/29/2014 32 Documents originating from NAFDAC and used for the clearance of NAFDAC regulated products S/NO DESCRIPTION 1 NARCOTICS AND CONTROLLED SUBSTANCES DIRECTORATE (NCS) Permit to import Narcotics substances Permit to import Psychotropic and Other controlled Substances 2 CHEMICAL EVALUATION AND RESEARCH DIRECTORATE (CER) Permit to import Controlled Chemicals and Solvents 3 REGISTRATION AND REGULATORY AFFAIRS DIRECTORATE (R&R) Certificate of Registration/Notification of Registration Preferably 2013 - 2014 NAFDAC: Operations
  • 33. Functions of Nigeria Customs Service in the Nigerian Economy: i. Revenue Collection  Customs & Excise Management Act, Cap 84 Laws of the Federation [CEMA, Section 4], LFN.1990 – power to control and manage administration of the Customs & Excise Laws. Collects and account for revenue.  [ii] Anti – smuggling operations Applicable at: Borders, sea and airports – checks contrabands, hazardous goods, national security interest.  Physical interception, examination of goods and documents.  33
  • 34. Functions of Nigeria Customs Service in the Nigerian Economy:  Agency Function (Inter-Agency)  NCS performs inter-agency functions on behalf of other government agencies, namely;  Nigeria Police Force – seizure of arms and ammunitions.  National Agency for Food and Drug Administration and Control [NAFDAC] – prevents illegal importation of foods, drugs and chemicals.  National Drug Law Enforcement Agency [NDLEA] – prevents importation and exportation of hard drugs. 34
  • 35. Nigeria Customs Service (NCS):Trade Facilitation Objectives  Generation of Trade Statistics  Trade Facilitation  Trade facilitation at the core of Customs operations due to the following  Developments in the WTO with emphasis on trade liberalization and facilitation.  Development of Free Trade Areas across the regions of the world – removing tariff and non-tariff barriers to speed up economic development .  NCS strategic positions at the entry and exit points of Nigerian borders; lead agency role 35
  • 36. Nigeria Customs Service (NCS): Trade Facilitation Objectives  To improve the trade environment and reduce transactions cost between business and government.  To attract Foreign Direct Investment (FDI).  To make Nigeria’s borders competitive by un-impeded flow of goods, services and investment funds through the borders. 36
  • 37. I. Implementation of global best practices as a core objective of NCS modernization agenda. II. Revised Kyoto Convention (RKC) on the simplification and harmonization of Customs procedures- Pre- lodgement and Pre-registration. III. WCO guidelines on immediate release of consignment - PreArrival processing. IV. Facilitation of trade through provision of adequate & accurate information in the Nigeria Trade Hub Portal (NTH). NCS New PAAR Policy
  • 38. What is PAAR? •P- Pre •A- Arrival •A- Assessment •R- Report •Pre-Arrival Assessment Regime allows importer/Agents to submit import Documents for assessment and issuance of PAAR (for Clearance) before the arrival of the cargo
  • 39. PAAR Application provides timely multi-dimensional risk analysis at every stage of Customs processes.
  • 40. Risk Management Approach in Customs Controls  Risk: The potential for non-compliance with Customs (& NAFDAC) laws.  Risk analysis: Systematic use of available information to determine how often defined risks may occur and the magnitude of their likely consequences.  Risk areas: Those Customs procedures and categories of international traffic which present a risk.
  • 41. Risk Management Approach in Customs Controls...2  Risk assessment: The systematic determination of risk management priorities by evaluating and comparing the level of risk against predetermined standards, target risk levels or other criteria.  Risk indicators: Specific criteria which, when taken together, serve as a practical tool to select and target movements for their potential for non-compliance with Customs law.
  • 42. Risk Management Approach in Customs Controls...3  Risk management: Logical and systematic method of identifying, analyzing and managing risks. Risk management can be associated with any activity, function or process within the organization and will enable the organization to take advantage of opportunities and minimize potential losses.
  • 43. Risk Management Approach in Customs Controls...4  Risk profile: A predetermined, comprehensive and relevant combination of characteristics or risk indicators, based on information which has been gathered, analyzed and categorized.
  • 44. Risk Management Approach in Customs Controls...5  Risk profiling: The means by which Customs put risk management into practice. It replaces random examination of documents and goods with planned and targeted working methods that use profiles as a basis.  Standardized Risk Assessments (SRAs): These Assessments produce risk indicator products for use by Customs officials for the purpose of targeting goods and conveyances in their daily work.
  • 45. Consumer Protection  Service Failure  Arising from Agencies and Service Providers  Remedy  Waive Penalties for Infractions that are beyond the control of Companies  Dispute Resolution Mechanism  No Agency must be allowed to be Prosecutor, Judge and Jury
  • 46. Best Practice: Customs Trade Compliance  Focused Assessments (FA)  a detailed review of the company's internal controls for Customs transactions coupled with an audit of selected import transactions.  Goal: determine the company's current level of compliance, and whether or not there are sufficient systems in place to ensure a high level of compliance with Customs laws and regulations for future transactions.  Outcome: Compliant or Non-Compliant.  If Non-Compliant, the company will be required to formulate a compliance improvement plan (CIP), and tender any revenue found to be owing.
  • 47. Getting it Right: Facilitation, not Encumbrance!
  • 48. Summary  Globalisation:  Has led to greatly increased volume of Global and Cross-Border Trade  Increased fortunes for developed nations and increased opportunities for smart developing nations  Developing nations need to take advantage of Globalisation for prosperity while avoiding inequalities of wealth distribution  All need to be aware of the risks that have come with Globalisation and mitigate against them  Cross-Border Trade:  Essentialy between Neighbours  Regional Cooperation is enlightened self-interest and should be encouraged  Inventory the relevant National laws/regulations and harmonise across the region  Keep all stakeholders actively informed and involved
  • 49. Summary  Trade Compliance:  Conventionally driven by Customs  Customs should regularly compile and communicate Compliance Issues/Breaches to Industry with a view to aiding improvement  Goal should be facilitation of Trade not encumbrance  Policy implementation must be customer-centric and culture must be to protect consumer rights while pursuing National Interest  Dispute Resolution Systems and Structure must be established  Cross-Border Pharmaceutical Trade (CBPT):  Deference should be given to the difference between Professionally Regulated Pharmaceutical Trade and Trade in General Goods  There should be greater inter-agency collaboration especially between Customs and NAFDAC given the key role the latter plays in regulating CBPT  Companies need to establish Compliance Management Desks and give it appropriate Executive Oversight
  • 50. Thank You! Contact Information: Remi ADESEUN Chairman Programs Committee Pharmaceutical Society of Nigeria 08057713769/07065156473 radeseun@gmail.com r.adeseun@rodot.org

Editor's Notes

  1. Why do we have such daunting figures?